Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
December 16, 2014
Richard Branson once wrote: “I have always valued capability over expertise. While you may need to hire specialists for...
Read article
December 9, 2014
Drug Supply Planning for Dose-Ranging Adaptive Trials
When planning a conventional trial, one can anticipate the drug supply necessary for the trial by determining how the...
Read article
September 2, 2014
Impact of Study Design and Development Strategy on Pharmaceutical Programs and Portfolios
As more clinical trials make use of adaptive designs, investors have come to realize that high quality trial designs...
Read article
August 5, 2014
Reflections on Statistical Entrepreneurship: An Interview with Nitin Patel
Cytel CTO Nitin Patel, recently sat down with ECHOES (a magazine for statistics in clinical trials) to discuss his...
Read article
May 5, 2014
The Perils of Poor Recruitment
A new JAMA study on discontinued randomized trials in Switzerland, Germany and Canada, reports that poor recruitment...
Read article
April 21, 2014
StatXact 25th Anniversary: A Horizon for the Stars
The core methodological problem that would eventually spur the development of Cytel’s StatXact software was first posed...
Read article